These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30593831)

  • 1. Rigorous control of vesicle-forming lipid pK
    Okamoto A; Koide H; Morita N; Hirai Y; Kawato Y; Egami H; Hamashima Y; Asai T; Dewa T; Oku N
    J Control Release; 2019 Feb; 295():87-92. PubMed ID: 30593831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective RNA interference and gene silencing using reactive oxygen species-responsive lipid nanoparticles.
    Liang C; Chang J; Jiang Y; Liu J; Mao L; Wang M
    Chem Commun (Camb); 2019 Jul; 55(56):8170-8173. PubMed ID: 31241120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core.
    Nakamura T; Yamada K; Fujiwara Y; Sato Y; Harashima H
    Mol Pharm; 2018 Jun; 15(6):2142-2150. PubMed ID: 29668291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference.
    Desigaux L; Sainlos M; Lambert O; Chevre R; Letrou-Bonneval E; Vigneron JP; Lehn P; Lehn JM; Pitard B
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16534-9. PubMed ID: 17923669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key determinants of siRNA delivery mediated by unique pH-responsive lipid-based liposomes.
    Sako M; Song F; Okamoto A; Koide H; Dewa T; Oku N; Asai T
    Int J Pharm; 2019 Oct; 569():118606. PubMed ID: 31415879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA.
    Lin PJ; Tam YY; Hafez I; Sandhu A; Chen S; Ciufolini MA; Nabi IR; Cullis PR
    Nanomedicine; 2013 Feb; 9(2):233-46. PubMed ID: 22698807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo.
    Jayaraman M; Ansell SM; Mui BL; Tam YK; Chen J; Du X; Butler D; Eltepu L; Matsuda S; Narayanannair JK; Rajeev KG; Hafez IM; Akinc A; Maier MA; Tracy MA; Cullis PR; Madden TD; Manoharan M; Hope MJ
    Angew Chem Int Ed Engl; 2012 Aug; 51(34):8529-33. PubMed ID: 22782619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembly of poly(allylamine)/siRNA nanoparticles, their intracellular fate and siRNA delivery.
    Di Silvio D; Martínez-Moro M; Salvador C; de Los Angeles Ramirez M; Caceres-Velez PR; Ortore MG; Dupin D; Andreozzi P; Moya SE
    J Colloid Interface Sci; 2019 Dec; 557():757-766. PubMed ID: 31569055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient siRNA delivery based on PEGylated and partially quaternized polyamine nanogels: enhanced gene silencing activity by the cooperative effect of tertiary and quaternary amino groups in the core.
    Tamura A; Oishi M; Nagasaki Y
    J Control Release; 2010 Sep; 146(3):378-87. PubMed ID: 20621664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
    Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
    Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells.
    Warashina S; Nakamura T; Sato Y; Fujiwara Y; Hyodo M; Hatakeyama H; Harashima H
    J Control Release; 2016 Mar; 225():183-91. PubMed ID: 26820519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The study of relationships between pKa value and siRNA delivery efficiency based on tri-block copolymers.
    Du L; Wang C; Meng L; Cheng Q; Zhou J; Wang X; Zhao D; Zhang J; Deng L; Liang Z; Dong A; Cao H
    Biomaterials; 2018 Sep; 176():84-93. PubMed ID: 29870899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioreducible poly (β-amino esters)/shRNA complex nanoparticles for efficient RNA delivery.
    Yin Q; Gao Y; Zhang Z; Zhang P; Li Y
    J Control Release; 2011 Apr; 151(1):35-44. PubMed ID: 21244853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo.
    Biscans A; Coles A; Echeverria D; Khvorova A
    J Control Release; 2019 May; 302():116-125. PubMed ID: 30940496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.